Reata Pharma (RETA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,843 | 84,940 | 42,312 | 31,918 | 147,154 |
| Marketable Securities | 281,371 | 236,019 | 345,202 | 403,957 | 334,317 |
| Receivables | 22,662 | N/A | N/A | N/A | N/A |
| Inventories | 2,942 | N/A | N/A | N/A | N/A |
| TOTAL | $401,849 | $332,542 | $397,770 | $445,104 | $491,210 |
| Non-Current Assets | |||||
| PPE Net | 11,303 | 11,060 | 11,179 | 11,263 | 11,033 |
| Other Non-Current Assets | 89,435 | 109,980 | 105,542 | 127,277 | 129,306 |
| TOTAL | $100,738 | $121,040 | $116,721 | $138,540 | $140,339 |
| Total Assets | $502,587 | $453,582 | $514,491 | $583,644 | $631,549 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 19,860 | 14,448 | 18,706 | 7,518 | 7,754 |
| Other current liabilities | 77,641 | 17,499 | 24,267 | 19,910 | 16,121 |
| TOTAL | $125,093 | $54,598 | $58,960 | $50,711 | $46,325 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,130 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 217,073 | 529,657 | 521,226 | 528,417 | 516,588 |
| TOTAL | $290,203 | $529,657 | $521,226 | $528,417 | $516,588 |
| Total Liabilities | $415,296 | $584,255 | $580,186 | $579,128 | $562,913 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 38,150 | 37,551 | 36,726 | 36,644 | 36,497 |
| Common Shares | 38 | 38 | 37 | 37 | 37 |
| Retained earnings | -1,490,651 | -1,683,649 | -1,567,532 | -1,482,030 | -1,403,028 |
| TOTAL | $87,291 | $-130,673 | $-65,695 | $4,516 | $68,636 |
| Total Liabilities And Equity | $502,587 | $453,582 | $514,491 | $583,644 | $631,549 |